2023 Insider Sell of Privia Health Group Revealed.

March 21, 2023

Trending News 🌥️

The year is 2023, and news of insiders of the Privia Health ($NASDAQ:PRVA) Group selling their shares has been revealed. According to a recent financial report, a large number of Privia Health’s executives and board members are taking advantage of a favorable market situation to offload their shares in the company. This news comes as a surprise to many, as Privia Health has enjoyed tremendous growth in the past few years. Privia Health is a healthcare technology and services provider, specializing in population health management and data analytics. Despite the recent news of insiders selling their shares, industry experts remain optimistic about the company’s future. Privia Health is well positioned to capitalize on the growing demand for healthcare analytics and data-driven solutions.

Moreover, its experience in population health management will be invaluable in helping healthcare providers manage their patient populations more efficiently. It remains to be seen how this insider sell-off will affect Privia Health Group in the long term. In the meantime, investors are advised to exercise caution when considering investing in the company at this time. With the strong demand for healthcare solutions and services, Privia Health may still secure a bright future ahead of it.

Price History

On Tuesday, the market saw a dramatic sell of PRIVIA HEALTH stock that opened at $26.7 and closed at $26.1. It remains unclear who exactly is behind the sudden sell but it is likely to be an insider familiar with the company’s fundamentals. With no clear reason for the sell, it is hard to tell what it may mean for the future of PRIVIA HEALTH.

However, after the sell, the stock price did not see any further decrease, indicating that this could be a one-time event. Whatever the reason may be, investors should pay attention to PRIVIA HEALTH’s future performance as they consider investing in the company. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Privia Health. More…

    Total Revenues Net Income Net Margin
    1.36k -8.59 -0.6%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Privia Health. More…

    Operations Investing Financing
    47.2 -0.1 -19.68
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Privia Health. More…

    Total Assets Total Liabilities Book Value Per Share
    792.81 273.76 4.35
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Privia Health are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    19.9% -1.4%
    FCF Margin ROE ROA
    3.5% -2.5% -1.5%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we have completed an analysis of PRIVIA HEALTH‘s financials. Our Risk Rating indicates that PRIVIA HEALTH is a medium risk investment in terms of financial and business aspects. We have detected one risk warning in the income sheet. To find out more, register on goodwhale.com and check out our detailed insights. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis


  • Peers

    Privia Health Group Inc is one of the leading players in the healthcare industry, competing against PreAxia Health Care Payment Systems Inc, Livecare Inc, and Evolent Health Inc, among others. These companies all strive to provide the best healthcare services and solutions for their customers, driving innovation in the industry and pushing each other to be better. As such, competition between Privia and its competitors has become increasingly fierce over the years.

    – PreAxia Health Care Payment Systems Inc ($OTCPK:PAXH)

    Axia Health Care Payment Systems Inc is a leading healthcare payments processor, providing a comprehensive suite of solutions to help providers streamline the revenue cycle management process. With a market capitalization of 1.12 million as of 2022, the company is well-positioned to continue its growth trajectory in the healthcare payments space. Additionally, Axia’s Return on Equity (ROE) of 5.11% provides investors with a solid return on their investment. The company’s solutions help reduce administrative costs, minimize fraud and compliance risks, and track payments across multiple channels. Axia’s payment solutions are used by thousands of providers, health plans, and other healthcare organizations around the world.

    – Livecare Inc ($OTCPK:LVCE)

    Evolent Health Inc is a health care technology company that provides services to providers and health plans in the United States. The company has a market cap of 2.79B as of 2022, making it one of the largest publicly traded companies in the healthcare industry. The company has a negative return on equity of -3.43%, indicating that it is not able to generate a consistent return from its assets and investments. This suggests that the company is not maximizing its potential earnings and overall shareholder value. Evolent Health Inc is focused on transforming the healthcare delivery system by providing innovative technology, analytics, and consulting solutions to providers, health plans, and other stakeholders.

    Summary

    Privia Health Group is a healthcare technology company focused on providing providers with actionable insights and data-driven solutions to improve patient outcomes. The company has recently seen an insider sell of its stock, which could be an indicator of the stock’s performance in the near future. Analysts recommend that potential investors take into account the financial health of the company and its competitive landscape before considering investing in Privia Health.

    Industry experts have speculated that Privia Health’s primary competitors are leveraging the digital health landscape more effectively and thus could pose a significant threat to its profitability. This could be a sign of high leverage and suggests that investors should be mindful of the associated risks.

    Recent Posts

    Leave a Comment